These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
548 related items for PubMed ID: 34571587
1. The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls. Lee HL, Lee SW. Clin Mol Hepatol; 2022 Apr; 28(2):121-134. PubMed ID: 34571587 [Abstract] [Full Text] [Related]
2. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension. Colombato L. J Clin Gastroenterol; 2007 Apr; 41 Suppl 3():S344-51. PubMed ID: 17975487 [Abstract] [Full Text] [Related]
3. Transjugular Intrahepatic Portosystemic Shunt (TIPS): Pathophysiologic Basics, Actual Indications and Results with Review of the Literature. Strunk H, Marinova M. Rofo; 2018 Aug; 190(8):701-711. PubMed ID: 30045395 [Abstract] [Full Text] [Related]
4. Reduction of portosystemic gradient during transjugular intrahepatic portosystemic shunt achieves good outcome and reduces complications. Luo SH, Zhou MM, Cai MJ, Han SL, Zhang XQ, Chu JG. World J Gastroenterol; 2023 Apr 21; 29(15):2336-2348. PubMed ID: 37124886 [Abstract] [Full Text] [Related]
5. Transjugular intrahepatic portosystemic shunt (TIPS) versus laparoscopic splenectomy (LS) plus preoperative endoscopic varices ligation (EVL) in the treatment of recurrent variceal bleeding. Zhou J, Wu Z, Wu J, Wang X, Li Y, Wang M, Yang Z, Peng B, Zhou Z. Surg Endosc; 2013 Aug 21; 27(8):2712-20. PubMed ID: 23392981 [Abstract] [Full Text] [Related]
7. Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience. Kraglund F, Jepsen P, Amanavicius N, Aagaard NK. Scand J Gastroenterol; 2019 Jul 21; 54(7):899-904. PubMed ID: 31203699 [Abstract] [Full Text] [Related]
8. [Comparison of the curative effect of transjugular intrahepatic portosystemic shunt with expanded polytetrafluoroethylene-covered stent and drug combined with gastroscopy as the secondary prevention of esophageal -gastric variceal bleeding in portal hypertension]. Lin ZP, Chen SL, Wang JY, Liu F, Tan Q, Peng QF, Zhao JB. Zhonghua Gan Zang Bing Za Zhi; 2020 Aug 20; 28(8):672-678. PubMed ID: 32911906 [Abstract] [Full Text] [Related]
9. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy. Luo SH, Chu JG, Huang H, Zhao GR, Yao KC. World J Gastroenterol; 2019 Mar 07; 25(9):1088-1099. PubMed ID: 30862997 [Abstract] [Full Text] [Related]
10. Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update. Rajesh S, George T, Philips CA, Ahamed R, Kumbar S, Mohan N, Mohanan M, Augustine P. World J Gastroenterol; 2020 Oct 07; 26(37):5561-5596. PubMed ID: 33088154 [Abstract] [Full Text] [Related]
11. [Transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding in liver cirrhosis: intended population and timing]. Lyu Y, Han GH, Fan DM. Zhonghua Gan Zang Bing Za Zhi; 2017 Jun 20; 25(6):402-407. PubMed ID: 28763854 [Abstract] [Full Text] [Related]
12. Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal Hypertension: Review and Update of the Literature. Hung ML, Lee EW. Clin Liver Dis; 2019 Nov 20; 23(4):737-754. PubMed ID: 31563220 [Abstract] [Full Text] [Related]
14. Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein. Li ZP, Wang SS, Wang GC, Huang GJ, Cao JQ, Zhang CQ. Hepatobiliary Pancreat Dis Int; 2018 Dec 20; 17(6):517-523. PubMed ID: 30262421 [Abstract] [Full Text] [Related]
15. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage. Sahagun G, Benner KG, Saxon R, Barton RE, Rabkin J, Keller FS, Rosch J. Am J Gastroenterol; 1997 Sep 20; 92(9):1444-52. PubMed ID: 9317060 [Abstract] [Full Text] [Related]
16. [Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of complications of portal hypertension in patients with liver cirrhosis]. Grønbaek H, Astrup LB, Nielsen DT, Vilstrup H. Ugeskr Laeger; 2003 Jan 27; 165(5):439-42. PubMed ID: 12599838 [Abstract] [Full Text] [Related]
17. Outcomes of Transjugular Intrahepatic Portosystemic Shunt and Gastric Coronary Vein Embolization for Variceal Bleeding in Cirrhotic Portal Hypertension. Mukhiya G, Han X, Jiao D, Bi Y, Pokhrel G, Liu Z, Li Z, He Y. Clin Med Res; 2023 Sep 27; 21(3):144-154. PubMed ID: 37985166 [Abstract] [Full Text] [Related]
18. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications. Siramolpiwat S. World J Gastroenterol; 2014 Dec 07; 20(45):16996-7010. PubMed ID: 25493012 [Abstract] [Full Text] [Related]
19. Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020. Horhat A, Bureau C, Thabut D, Rudler M. United European Gastroenterol J; 2021 Mar 07; 9(2):203-208. PubMed ID: 32819214 [Abstract] [Full Text] [Related]
20. TIPS for management of portal-hypertension-related complications in patients with cirrhosis. Allaire M, Walter A, Sutter O, Nahon P, Ganne-Carrié N, Amathieu R, Nault JC. Clin Res Hepatol Gastroenterol; 2020 Jun 07; 44(3):249-263. PubMed ID: 31662286 [Abstract] [Full Text] [Related] Page: [Next] [New Search]